A yeast-derived antigen from Paracoccidioides brasiliensis useful for serologic testing

Area of Science:

• Mycology
• Immunology
• Infectious Diseases

Background:

• Paracoccidioidomycosis (PNM) is a systemic fungal infection endemic to Latin America.
• Accurate serological diagnosis is crucial for effective PNM management.
• Traditional diagnostic antigens have limitations in reproducibility and specificity.

Purpose of the Study:

• To evaluate novel antigens derived from ultrasonically treated *Paracoccidioides brasiliensis* yeast cells for PNM serodiagnosis.
• To compare the performance of these new antigens with existing diagnostic standards.

Main Methods:

• Preparation of antigens from *P. brasiliensis* yeast cells using ultrasonic treatment.
• Serological testing of patient sera using agar gel immunodiffusion (AGID) and counterimmunoelectrophoresis (CIE).
• Assessment of diagnostic sensitivity and specificity, including cross-reactivity with histoplasmosis sera.

Main Results:

• The novel antigens demonstrated high reliability in detecting antibodies in over 90% of confirmed PNM patients.
• High specificity was observed, with only a low frequency (10%) of cross-reactivity in histoplasmosis sera.
• The new antigens showed comparable or superior performance to the standard yeast culture filtrate antigen.
• Reproducibility of the new antigens was a significant advantage over previous methods.

Conclusions:

• Ultrasonically treated *P. brasiliensis* antigens are effective and reproducible tools for the serodiagnosis of paracoccidioidomycosis.
• These antigens offer improved diagnostic accuracy and reliability compared to conventional methods.
• Further optimization, including control of proteolysis, is recommended to preserve antigen activity.